[子宫肉瘤的国际妇产科联盟（FIGO）新分期] - Suppr

Suppr

超能文献

[New FIGO staging for uterine sarcomas].

作者信息

Horn L-C, Schmidt D, Fathke C, Ulrich U

机构信息

Institut für Pathologie, Abteilung Mamma-, Gynäko- & Perinatalpathologie, Universität Leipzig, Leipzig, Deutschland.

出版信息

Pathologe. 2009 Jul;30(4):302-3. doi: 10.1007/s00292-009-1158-8.

DOI:10.1007/s00292-009-1158-8

PMID:19513716

Abstract

摘要

相似文献

[New FIGO staging for uterine sarcomas].

Pathologe. 2009 Jul;30(4):302-3. doi: 10.1007/s00292-009-1158-8.

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Primary or secondary laparoscopy for staging in patients with uterine sarcoma.

Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):230-1. doi: 10.1016/j.ejogrb.2010.10.011. Epub 2010 Nov 20.

[Uterine sarcoma treatment].

Pathologe. 2009 Jul;30(4):304-12. doi: 10.1007/s00292-009-1150-3.

Staging of uterine sarcomas.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):733-49. doi: 10.1016/j.bpobgyn.2011.05.011. Epub 2011 Jul 14.

Uterine sarcomas.

Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S105-10. doi: 10.1016/j.ijgo.2015.06.006.

Uterine sarcomas.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:51-58. doi: 10.1002/ijgo.12613.

[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].

Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.

Uterine sarcomas: a review.

Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23.

[TNM 2010. What's new?].

Pathologe. 2010 Oct;31 Suppl 2:153-60. doi: 10.1007/s00292-010-1341-y.

引用本文的文献

Effect of tumor morcellation in patients with early uterine sarcoma: a multicenter study in Germany.

J Turk Ger Gynecol Assoc. 2022 Jun 1;23(2):75-82. doi: 10.4274/jtgga.galenos.2022.2021.9-17. Epub 2022 Mar 10.

-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of /-Wild-Type Tumor With Frequent Genomic Alterations and 1p/19q-Codeletion.

JCO Precis Oncol. 2020 Sep 1;4. doi: 10.1200/PO.20.00040. eCollection 2020.

Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.

Oncol Lett. 2015 Jul;10(1):342-348. doi: 10.3892/ol.2015.3177. Epub 2015 May 6.

[Changes in the TNM classification of gynecological tumors].

Pathologe. 2010 Sep;31(5):367-73. doi: 10.1007/s00292-010-1308-z.

[Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].

Pathologe. 2011 May;32(3):239-43. doi: 10.1007/s00292-010-1273-6.

本文引用的文献

[Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].

Pathologe. 2009 Jul;30(4):292-301. doi: 10.1007/s00292-009-1153-0.

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

J Clin Pathol. 2002 May;55(5):321-5. doi: 10.1136/jcp.55.5.321.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[New FIGO staging for uterine sarcomas].

Pathologe. 2009 Jul;30(4):302-3. doi: 10.1007/s00292-009-1158-8.

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Primary or secondary laparoscopy for staging in patients with uterine sarcoma.

Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):230-1. doi: 10.1016/j.ejogrb.2010.10.011. Epub 2010 Nov 20.

[Uterine sarcoma treatment].

Pathologe. 2009 Jul;30(4):304-12. doi: 10.1007/s00292-009-1150-3.

Staging of uterine sarcomas.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):733-49. doi: 10.1016/j.bpobgyn.2011.05.011. Epub 2011 Jul 14.

Uterine sarcomas.

Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S105-10. doi: 10.1016/j.ijgo.2015.06.006.

Uterine sarcomas.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:51-58. doi: 10.1002/ijgo.12613.

[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].

Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.

Uterine sarcomas: a review.

Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23.

[TNM 2010. What's new?].

Pathologe. 2010 Oct;31 Suppl 2:153-60. doi: 10.1007/s00292-010-1341-y.

引用本文的文献

Effect of tumor morcellation in patients with early uterine sarcoma: a multicenter study in Germany.

J Turk Ger Gynecol Assoc. 2022 Jun 1;23(2):75-82. doi: 10.4274/jtgga.galenos.2022.2021.9-17. Epub 2022 Mar 10.

-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of /-Wild-Type Tumor With Frequent Genomic Alterations and 1p/19q-Codeletion.

JCO Precis Oncol. 2020 Sep 1;4. doi: 10.1200/PO.20.00040. eCollection 2020.

Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.

Oncol Lett. 2015 Jul;10(1):342-348. doi: 10.3892/ol.2015.3177. Epub 2015 May 6.

[Changes in the TNM classification of gynecological tumors].

Pathologe. 2010 Sep;31(5):367-73. doi: 10.1007/s00292-010-1308-z.

[Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].

Pathologe. 2011 May;32(3):239-43. doi: 10.1007/s00292-010-1273-6.

本文引用的文献

[Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].

Pathologe. 2009 Jul;30(4):292-301. doi: 10.1007/s00292-009-1153-0.

FIGO staging for uterine sarcomas.

Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

J Clin Pathol. 2002 May;55(5):321-5. doi: 10.1136/jcp.55.5.321.